# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
As Benzinga Cannabis Capital Conference returns on September 13-14 to Chicago, gathering top CEOs, investors and leaders in th...
Canntab Therapeutics Limited (OTCQB: CTABF) (CSE: PILL.CN) (FRA: TBF1.F) has entered into an affiliate agreement with OnPharm-U...
Canntab Therapeutics Limited (CSE:PILL) (OTCQB: CTABF) (FRA:TBF1) has announced a strategic planning collaboration and commerci...
Canntab Therapeutics Limited (CSE:PILL) (OTCQB: CTABF) (FRA:TBF1) confirmed Tuesday it has closed a non-brokered private place...
Cannabinoid company Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) launched its online e-commerce platform...
Wellness company Levitee Labs Inc. (CSE: LVT) (OTC: LVTTF) (FSE:7H7) confirmed Monday that it has teamed up with cannabinoid co...
Canntab Therapeutics Limited (CSE: PILL.CN) (OTCQB: CTABF) (FRA: TBF1.F), an innovator in cannabinoid and terpene blends, said ...